Novel Immunotherapeutics Summit


The Novel Immunotherapeutics Summit will bring together a balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain fresh perspective on the various research happening.

The Summit will begin with a plenary keynote session, and then break into four concurrent conferences, all of which will talk about complementary areas of the latest breakthroughs in the immunology field:


12th Cytokines & Inflammation

This meeting provides a forum for researchers to discuss the latest advances in targeting cytokines and chemokines for therapeutic interventions, cytokines and metabolism, and cytokines signaling pathways.


6th Immunotherapeutics & Immunomonitoring

Leading experts will cover recent advances in immunotherapy and how they relate to various immunotherapy modalities, specific cancers, cell subsets, animal models, and tumor microenvironment.


2nd Immunogenicity and Immunotoxicity

Delegates will learn about ongoing research for tools to mitigate risks associated with the immunogenicity of therapeutic proteins.


Inaugural Innate Immunity

Come to learn about discoveries in toll like receptors, inflammasome reactions, the role of the microbiome and non-pathogenic bacteria, and many more.


Attend the Pre-Summit Workshop on January 29, 2014! – Additional Registration Required

Novel Immunoassays Workshop – Platform & Methods

This pre-summit workshop will be a time for researchers and scientists who are interested in learning how to develop a reliable solid phase immunoassay (such as PK and ADA assays) to support biological drug development.


Contacts: phone: 626-256-6405, fax: 626-466-4433, email: [email protected]